Tamoxifen Citrate
- Strength
- 10 mg/1
- Form
- Tablet
- Class
- Estrogen Agonist/Antagonist
Actavis Pharma, Inc.
TAMOXIFEN CITRATE
Listed by Mayne Pharma
| Dosage form | Liquid |
|---|---|
| Route | Oral |
| Drug class | Estrogen Agonist/Antagonist |
| Approval route | NDA — original brand approval |
| NDC code | 51862-682 |
| FDA application | NDA021807 |
| RxNorm concept | 389230 |
| Package sizes listed | 2 |
| Marketed since | June 2021 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Actavis Pharma, Inc.
Actavis Pharma, Inc.
NuCare Pharmaceuticals, Inc.
Aurobindo Pharma Limited
A-S Medication Solutions
Proficient Rx LP
A-S Medication Solutions
Aurobindo Pharma Limited
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.